Synopsys, Inc. (SNPS) Financial Statements
Synopsys, Inc. (SNPS) reported trailing twelve-month revenue of $9.4B (up 46.3% year on year) and net income of $1.1B as of 2026-07-31, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $2.7B.
Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason
SNPSSynopsys, Inc.Follow SNPS — free
—
Price chart with a free account
- Market cap
- 82.4B
- P/E TTM
- 76.9
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 8 Dec, in 45 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jul 26.
| Line | FY2010 Oct 10 | FY2011 Oct 11 | FY2012 Oct 12 | FY2013 Oct 13 | FY2014 Oct 14 | FY2015 Oct 15 | FY2016 Oct 16 | FY2017 Oct 17 | FY2018 Oct 18 | FY2019 Oct 19 | FY2020 Oct 20 | FY2021 Oct 21 | FY2022 Oct 22 | FY2023 Oct 23 | FY2024 Oct 24 | FY2025 Oct 25 | TTM Jul 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.38 | 1.54 | 1.76 | 1.96 | 2.06 | 2.24 | 2.42 | 2.72 | 3.12 | 3.36 | 3.69 | 4.20 | 4.62 | 5.32 | 6.13 | 7.05 | 9.42 | |
| Gross profit | 1.10 | 1.20 | 1.36 | 1.51 | 1.60 | 1.72 | 1.88 | 2.07 | 2.39 | 2.61 | 2.89 | 3.34 | 3.72 | 4.29 | 4.88 | 5.43 | 6.82 | |
| Research & development | 0.45 | 0.49 | 0.58 | 0.67 | 0.72 | 0.78 | 0.86 | 0.91 | 1.08 | 1.14 | 1.28 | 1.50 | 1.59 | 1.85 | 2.08 | 2.48 | 2.88 | |
| Operating income | 0.18 | 0.21 | 0.19 | 0.25 | 0.25 | 0.27 | 0.32 | 0.35 | 0.36 | 0.52 | 0.62 | 0.73 | 1.15 | 1.27 | 1.36 | 0.91 | 0.80 | |
| Pre-tax income | 0.20 | 0.22 | 0.20 | 0.28 | 0.27 | 0.28 | 0.33 | 0.38 | 0.36 | 0.55 | 0.64 | 0.81 | 1.10 | 1.31 | 1.51 | 1.39 | 1.30 | |
| Income tax | -0.04 | -0.00 | 0.02 | 0.03 | 0.01 | 0.06 | 0.06 | 0.25 | -0.07 | 0.01 | -0.03 | 0.05 | 0.14 | 0.09 | 0.10 | 0.06 | 0.22 | |
| Net income | 0.24 | 0.22 | 0.18 | 0.25 | 0.26 | 0.23 | 0.27 | 0.14 | 0.43 | 0.53 | 0.66 | 0.76 | 0.98 | 1.23 | 2.26 | 1.33 | 1.08 | |
| Diluted EPS ($) | 1.56 | 1.47 | 1.21 | 1.58 | 1.64 | 1.43 | 1.73 | 0.88 | 2.82 | 3.45 | 4.27 | 4.81 | 6.29 | 7.92 | 14.51 | 8.04 | 5.59 | |
| Diluted shares (bn) | 0.152 | 0.150 | 0.150 | 0.157 | 0.158 | 0.158 | 0.155 | 0.155 | 0.153 | 0.154 | 0.156 | 0.157 | 0.156 | 0.155 | 0.156 | 0.166 | — |
USD billions · SEC XBRL
Synopsys, Inc. — questions
- What is Synopsys, Inc.'s revenue?
- $9.4B over the twelve months to 2026-07-31, up 46.3% year on year, from its 10-Q and 10-K filings.
- What is Synopsys, Inc.'s net income?
- $1.1B over the twelve months to 2026-07-31.
- What is Synopsys, Inc.'s free cash flow?
- $2.7B over the twelve months to 2026-07-31.
- What are Synopsys, Inc.'s diluted earnings per share?
- $5.59 over the twelve months to 2026-07-31.
Every figure on this page comes from Synopsys, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.